Bicycle Therapeutics (BCYC) Interest & Investment Income (2018 - 2026)

Bicycle Therapeutics has reported Interest & Investment Income for 9 years, with the latest figure at $4.9 million in Q1 2026.

• For the quarter ending Q1 2026, Interest & Investment Income fell 42.04% year-over-year to $4.9 million; the trailing twelve-month figure through Mar 2026 stood at $24.9 million (down 32.77% YoY), and the FY2025 full-year result was $28.5 million, down 16.98% from the prior year.
• Interest & Investment Income for Q1 2026 stood at $4.9 million, down from $5.9 million in the prior quarter.
• The five-year high for Interest & Investment Income was $10.6 million in Q3 2024, with the low at $218000.0 in Q1 2022.
• Historically, Interest & Investment Income has averaged $5.1 million across 5 years, with a median of $5.6 million in 2024.
• Annual changes were most pronounced in 2022 — Interest & Investment Income jumped 8195.83% — and 2025, when it sank 42.97%.
• Bicycle Therapeutics' Interest & Investment Income stood at $2.6 million in 2022, then soared by 137.82% to $6.3 million in 2023, then surged by 64.17% to $10.3 million in 2024, then sank by 42.97% to $5.9 million in 2025, then decreased by 17.0% to $4.9 million in 2026.
• The last three Interest & Investment Income figures came in at $4.9 million (Q1 2026), $5.9 million (Q4 2025), and $6.7 million (Q3 2025), per Business Quant data.